Recovery Techniques for Persistent Postural-Perceptual Dizziness

Refers to:

For a fuller description of this symptom and the diagnostic techniques used to assess it, see Understanding & Diagnosis.

• persistent non-spinning dizziness or unsteadiness;
• rocking, swaying or visually induced dizziness; and
• symptoms worsened by upright posture, movement or complex visual environments that meet PPPD criteria.

Scope boundary: PPPD is persistent by diagnostic definition—present on most days for at least three months—although severity can fluctuate. This page does not cover every brief dizzy spell, faint, balance problem or sudden fall; those appearances need their own assessment and recovery plan.

Also described as: PPPD, 3PD and persistent perceptual dizziness.

---

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For the Person With FND

Techniques used in treatment

Explore the thirteen detailed pages. Each original entry has one page; they include practical rehabilitation, care planning and specialist discussions, not thirteen proven exercises.

1. Individualized vestibular rehabilitation. When ongoing dizziness affects several parts of daily life and exercises need to match your assessed pattern. [Clinical rehabilitation with emerging PPPD evidence; no universal programme]
2. Habituation to head and body motion. When familiar, assessed movements such as turning towards a person or bending during a task reliably bring on dizziness. [Clinical adaptation within rehabilitation; standalone efficacy uncertain]
3. Graded upright exposure. When upright activity worsens an established PPPD pattern, with faintness and other causes assessed separately. [Individualized rehabilitation guidance; component efficacy uncertain]
4. Graded visual-motion exposure. When scrolling, passing traffic, shelves or moving crowds worsen assessed visually induced dizziness. [Clinical adaptation with limited PPPD-specific evidence]
5. Gaze-stability exercise when indicated. When assessment identifies a problem keeping vision clear during head movement that a gaze exercise is intended to address. [Adjacent vestibular-hypofunction guideline; not mandatory PPPD treatment]
6. Balance and gait practice. When assessed unsteadiness affects standing, turning or walking and practice needs to account for fall risk. [Clinical rehabilitation; adjacent balance evidence and limited PPPD component evidence]
7. Graded community activity. When dizziness has made a valued outing difficult and a practical, supported version could be explored. [Individualized participation planning within rehabilitation; standalone efficacy uncertain]
8. Psychologically informed vestibular rehabilitation. When symptom-related worry, constant monitoring or an assessed avoidance pattern makes rehabilitation harder and the person wants help with it. [Emerging CBT-informed package evidence; not proof of psychological causation]
9. Treat the precipitant and comorbidity. When migraine, positional vertigo, faintness, medicines or another condition may coexist with PPPD or change the treatment plan. [Diagnostic and clinical care guidance; not an isolated PPPD treatment]
10. Optokinetic or virtual-reality practice. When a specialist proposes technology to tailor visual practice and simpler options have been considered. [Emerging small-study evidence; optional specialist-selected adjunct]
11. Specialist neuromodulation or galvanic vestibular stimulation. When a qualified team proposes a stimulation device or research study and you want to understand its limits and alternatives. [Experimental or emerging evidence; no established self-treatment protocol]
12. SSRI or SNRI discussion. When medication is being considered for persistent dizziness or a coexisting condition and the benefits, risks and follow-up need to be clear. [Used in clinical practice; PPPD-specific placebo-controlled evidence uncertain]
13. Relapse plan. When stronger periods of familiar dizziness disrupt daily life and you need a clear plan for support, activity and reassessment. [Clinical self-management and care planning; standalone efficacy untested]

Managing a flare within a persistent condition

PPPD is different from the other symptom pages: established PPPD is persistent by definition, although severity may wax and wane and short periods of much stronger symptoms can occur. A flare means an increase above the person’s usual background; it is not a separate brief PPPD diagnosis.

During a familiar flare:

1. Prevent falls and stop hazardous activity. Sit, use the usual aid, or leave an unsafe moving/visual environment when needed.
2. Use the agreed easier version if it remains safe. Additional rest, practical help or a pause in exercises may be needed. There is no compulsory minimum dose during every flare.
3. Use the established vestibular strategy. Use prescribed balance support or another individually selected strategy. Fixing the gaze is not a universal rescue technique.
4. Resume progression after the flare settles. Return to the last repeatable dose before increasing complexity again.

A new severe pattern, fainting, new hearing loss, focal neurological symptoms, chest pain or persistent vomiting needs reassessment rather than being assumed to be a PPPD flare.

A low-risk starting practice

Choose one already-safe activity—such as sitting upright or a short walk on a clear, level route—and repeat a dose that produces only manageable, settling symptoms. Change one variable at a time and allow recovery. Stop for fainting, falls, new neurological symptoms, chest pain, severe headache, prolonged vomiting or a large sustained deterioration.

Ask for urgent help or reassessment when

Dizziness is sudden or distinctly different, or occurs with new weakness, double vision, speech trouble, inability to walk, severe headache, fainting, chest pain, hearing loss, head injury or persistent vomiting. Even established PPPD requires reassessment when falls, new ear/neurological signs or progressive functional loss occur.

---

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Family, Friends, and Other Supporters

• Do not deliberately expose the person to scrolling, supermarkets or rapid head movement to test the diagnosis.
• Help repeat the agreed dose and leave before symptoms become unmanageable.
• Offer steady support without pulling, and respect prescribed aids.
• Encourage return to meaningful places while accepting planned recovery time.
• Treat a new dizziness pattern as new information, not automatically as PPPD.

During a stronger flare

Help with fall safety and the person’s planned exit or recovery strategy. A temporary reduction in activity may be appropriate, but do not insist on either pushing through or prolonged complete avoidance. Support an easier activity if it is manageable; accept a pause when it is not. Help the person review the plan before building back up. New or distinctly different dizziness still deserves reassessment.

---

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Clinicians and the Care Team

Confirm the Bárány criteria and evaluate the precipitating and coexisting vestibular, migraine, neurological, cardiovascular and psychological conditions. Profile visual dependence, motion sensitivity, gaze, balance, gait, avoidance and fall risk. Explain the model without implying that symptoms are imaginary.

Flare planning within persistent PPPD

Document the Criterion A background separately from exacerbations: usual hours/day, severity, visual/motion/upright triggers, flare duration, precipitating context and recovery to baseline. Agree an optional reduced activity plan, practical assistance and explicit fall/reassessment thresholds. Do not prescribe a compulsory minimum dose when safe participation is not possible.

Set a baseline dose and progress one dimension at a time. Discuss CBT-informed support when an assessed monitoring, worry or avoidance pattern is relevant; do not infer that it caused PPPD. Measure participation and visually complex real-world function, not only symptom provocation. Discuss medication evidence honestly and coordinate migraine or psychiatric treatment as appropriate.

---

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

Research and Sources

Rehabilitation research is encouraging but does not identify one universal protocol. The 2025 vestibular-rehabilitation review included eight heterogeneous studies. The 2023 Cochrane reviews used strict diagnostic, comparator and follow-up criteria: no eligible medication trials and only one small non-drug trial remained. These results answer different questions; neither justifies saying every exercise works or that nothing can help. [2][3][4]

INVEST supports the feasibility of a CBT-informed rehabilitation package, not definitive efficacy or ACT-specific benefit. Small visual-technology studies and the 2026 stimulation network analysis remain preliminary. Peripheral-hypofunction guidelines are adjacent evidence and should not be copied as a PPPD prescription. The detailed pages state these population and evidence boundaries. [5][6][7][8]

No community-only technique or new quotation has been added. Everyday examples are educational adaptations. Medication safety guidance is general; prescribing remains individualized. [9]

Citation	Source	What it supports and its limits	Figure
1	FND-CIT-0027 — Staab JP, Eckhardt-Henn A, Horii A, et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the Committee for the Classification of Vestibular Disorders of the Bárány Society. Journal of Vestibular Research. 2017;27(4):191–208. DOI.	Diagnostic consensus; defines PPPD and differential assessment, not treatment efficacy.	—
2	FND-CIT-0038 — Li Y, Pei X, Ding R, et al. Effect of vestibular rehabilitation therapy in patients with persistent postural perceptual dizziness: a systematic review and meta-analysis. Frontiers in Neurology. 2025;16:1599201. DOI. Correction.	Heterogeneous rehabilitation studies; does not validate each exercise or a universal dose.	—
3	FND-CIT-0039 — Webster KE, Harrington-Benton NA, Judd O, et al. Pharmacological interventions for persistent postural-perceptual dizziness (PPPD). Cochrane Database of Systematic Reviews. 2023;3:CD015188. DOI.	No eligible SSRI/SNRI placebo/no-treatment trials under its criteria; historical review, not proof of no benefit.	—
4	FND-CIT-0040 — Webster KE, Kamo T, Smith L, et al. Non-pharmacological interventions for persistent postural-perceptual dizziness (PPPD). Cochrane Database of Systematic Reviews. 2023;3:CD015333. DOI.	Strict comparator and follow-up criteria left very limited evidence; not proof that rehabilitation cannot help.	—
5	FND-CIT-0041 — Shen J, Zhao X, Huo Y, et al. Comparative efficacy of non-pharmacological interventions for persistent postural-perceptual dizziness: a systematic review and network meta-analysis of balance, anxiety, and depression outcomes. Journal of Neurology. 2026;273:366. DOI.	Sparse network, mixed interventions and substantial bias; rankings are not a treatment recommendation.	—
6	FND-CIT-0192 — Herdman D, Norton S, Murdin L, Frost K, Pavlou M, Moss-Morris R. The INVEST trial: a randomised feasibility trial of psychologically informed vestibular rehabilitation versus current gold standard physiotherapy for people with Persistent Postural Perceptual Dizziness. Journal of Neurology. 2022;269:4753–4763. DOI.	Small feasibility comparison of treatment packages; does not establish component efficacy or ACT benefit.	—
7	FND-CIT-0193 — Hall CD, Herdman SJ, Whitney SL, et al. Vestibular Rehabilitation for Peripheral Vestibular Hypofunction: An Updated Clinical Practice Guideline From the Academy of Neurologic Physical Therapy of the American Physical Therapy Association. Journal of Neurologic Physical Therapy. 2022;46(2):118–177. DOI.	Guideline for peripheral vestibular hypofunction; adjacent evidence, not a PPPD exercise prescription.	—
8	FND-CIT-0194 — Choi SY, Choi JH, Oh EH, Oh SJ, Choi KD. Effect of vestibular exercise and optokinetic stimulation using virtual reality in persistent postural-perceptual dizziness. Scientific Reports. 2021;11:14437. DOI.	Small short-term study comparing VR exercise with versus without added visual-motion stimulation; no ordinary-care comparison.	—
9	FND-CIT-0195 — NHS. Antidepressants. Patient information. Accessed September 22, 2026.	General medicine safety and withdrawal information; not PPPD efficacy evidence.	—
10	FND-CIT-0196 — Neurosymptoms.org. Functional Dizziness (PPPD). Specialist patient information. Accessed September 22, 2026.	Specialist explanation and treatment context; not a controlled treatment trial.	—

Evidence checked: September 22, 2026 · Vestibular, neurology, lived-experience and accessibility review pending

---

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —